Twenty five years of learning to combat cervical cancer

by National Centre for Biological SciencesGlobal cervical cancer statistics 2018: Estimates of incidence and mortality. Credit:A Cancer Journal for Clinicians(2018). Volume 68, Issue: 6, P

Updated on: March 14,2024

Twenty five years of learning to combat cervical cancer

by National Centre for Biological SciencesGlobal cervical cancer statistics 2018: Estimates of incidence and mortality. Credit:A Cancer Journal for Clinicians(2018). Volume 68, Issue: 6, P

Updated on:March 14,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation

by Impact Journals LLCAnalysis of blood-based liquid biopsies in prostate cancer. Credit:Oncoscience(2023). DOI: 10.18632/oncoscience.592A new research perspective was published inOn

Updated on: January 02,2024

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation

by Impact Journals LLCAnalysis of blood-based liquid biopsies in prostate cancer. Credit:Oncoscience(2023). DOI: 10.18632/oncoscience.592A new research perspective was published inOn

Updated on:January 02,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on: April 09,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on:April 09,2024

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Updated on: January 23,2024

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Updated on:January 23,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on: April 30,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on:April 30,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on: April 09,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on:April 09,2024

Circulating tumor cell count guidance may improve long-term outcomes for patients with metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainThe use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-

Updated on: January 22,2024

Circulating tumor cell count guidance may improve long-term outcomes for patients with metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainThe use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-

Updated on:January 22,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on: September 27,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on:September 27,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on: January 23,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on:January 23,2024

Researchers identify new way to make cancer self-destruct

by Perelman School of Medicine at the University of PennsylvaniaATF4 is at a point after both pathways come back together. Credit: Penn MedicineFor years, researchers have been trying to target a

Updated on: June 19,2024

Researchers identify new way to make cancer self-destruct

by Perelman School of Medicine at the University of PennsylvaniaATF4 is at a point after both pathways come back together. Credit: Penn MedicineFor years, researchers have been trying to target a

Updated on:June 19,2024

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he

Updated on: October 21,2024

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he

Updated on:October 21,2024